Allon Therapeutics, Inc. reported unaudited earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported a net loss of $1,071,311 or $0.01 per share compared to $2,778,704 or $0.03 per share a year ago, representing a decrease in net loss of $1,707,393.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2013